PMU60 - IS TRANSPARENCY IN SLOVAK HTA EFFICIENT ENOUGHT? COMPARING PHARMACOECONOMICS METHODOLOGIES USED IN PRICING REIMBURSEMENT APPLICATIONS FOR INNOVATIVE THERAPIES TOWARDS REQUIREMENTS DEFINED BY THE LAW
Abstract
Authors
M Višňanský